Sarafem Related Published Studies
Well-designed clinical trials related to Sarafem (Fluoxetine)
Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. [2008.11]
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. [2008.09]
Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. [2008.09]
Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study. [2008.09]
A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder. [2008.08.01]
Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. [2008.06.15]
Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine. [2008.05]
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. [2008.04]
[Assessment of effectiveness of electroacupuncture and fluoxetine for treatment of depression with physical symptoms] [2008.03]
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. [2008.03]
Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: A randomized, open-label, 12-week, parallel-group trial. [2008.02.15]
Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. [2008]
SET-C versus fluoxetine in the treatment of childhood social phobia. [2007.12]
A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. [2007.11]
Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males. [2007.11]
Treatment of depression and anxiety in infertile women: Cognitive behavioral therapy versus fluoxetine. [2007.10.11]
Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial. [2007.10]
Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. [2007.07]
Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. [2007.04]
An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction. [2007.04]
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. [2007.04]
Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. [2007.03.30]
Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. [2007.03]
Effects of reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety. [2007.03]
Effects of electroacupuncture and fluoxetine on the density of GTP-binding-proteins in platelet membrane in patients with major depressive disorder. [2007.03]
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. [2007.02.15]
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. [2007.02]
Fluoxetine, smoking, and history of major depression: A randomized controlled trial. [2007.02]
Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. [2007.02]
A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. [2007.01]
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. [2007]
Fluoxetine is not effective in the treatment of post-stroke fatigue: a double-blind, placebo-controlled study. [2007]
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine. [2007]
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). [2007]
Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. [2007]
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. [2006.12]
Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial. [2006.11]
Bioequivalence study of two fluoxetine capsule formulations in healthy Middle Eastern volunteers. [2006.11]
Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. [2006.11]
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. [2006.09]
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. [2006.07]
Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. [2006.06.14]
Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. [2006.06.13]
Are All Antidepressants Really the Same? The Case of Fluoxetine: A Systematic Review. [2006.06]
Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial. [2006.05]
A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. [2006.05]
[Efficacy of buspirone and fluoxetine in short-term treatment of bulimia nervosa] [2006.01]
Bioequivalence testing of a new tablet formulation of generic fluoxetine. [2006.01]
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression. [2006]
Well-designed clinical trials possibly related to Sarafem (Fluoxetine)
Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial. [2008.10.08]
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. [2008.10]
Newer antidepressants for hot flashes-should their efficacy still be up for debate? [2008.08.22]
Maternal depressive symptoms in pediatric major depressive disorder: relationship to acute treatment outcome. [2008.06]
Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: a randomized clinical trial, posttreatment outcomes, and six-month follow-up. [2008.06]
Dimensional personality traits and treatment outcome in patients with major depressive disorder. [2008.06]
Cost-effectiveness of treatments for adolescent depression: results from TADS. [2008.05]
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. [2008.05]
A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial. [2008.05]
Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. [2008.04]
The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. [2008.04]
rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex. [2008.03]
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. [2008.02.27]
Trajectories of improvement for six depression-related outcomes. [2008.01]
Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670. [2008.01]
Managing the patient with co-morbid depression and an anxiety disorder. [2008]
An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features. [2008]
Continuation and maintenance use of antidepressants in recurrent depression. [2008]
Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. [2008]
Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population. [2008]
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases. [2007.12.15]
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials. [2007.12]
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. [2007.12]
Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS). [2007.12]
Effect of comorbid anxiety on treatment response in bipolar depression. [2007.12]
Folate augmentation of treatment - evaluation for depression (FolATED): protocol of a randomised controlled trial. [2007.11.15]
Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial. [2007.11.10]
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder. [2007.11]
Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. [2007.11]
The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. [2007.10]
Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. [2007.10]
Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS). [2007.10]
A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children. [2007.09]
Risk factors for and correlates of poststroke depression following discontinuation of antidepressants. [2007.09]
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. [2007.08]
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. [2007.07.13]
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. [2007.07]
Does percent body fat predict outcome in anorexia nervosa? [2007.06]
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. [2007.06]
Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study. [2007.05]
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. [2007.04.18]
Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. [2007.04]
Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. [2007.04]
Effect of antidepressant therapy on executive function after stroke. [2007.03]
fMRI predictors of treatment outcome in pediatric anxiety disorders. [2007.03]
Extreme response style in recurrent and chronically depressed patients: change with antidepressant administration and stability during continuation treatment. [2007.02]
[Clinical observation on treatment of melancholia by acupuncture following principle of relieving depression and regulating mentality] [2007.02]
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial. [2007.02]
The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. [2007.01]
Determination of paroxetine in plasma by liquid chromatography coupled to tandem mass spectrometry for pharmacokinetic and bioequivalence studies. [2007]
[Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy] [2007]
Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD. [2007]
|
